Loading...
Efficacy of Bacopa Monnieri (Brahmi) and Donepezil in Alzheimer's Disease and Mild Cognitive Impairment: A Randomized Double-Blind Parallel Phase 2b Study
OBJECTIVES: Alzheimer's disease (AD) is the most common cause of dementia worldwide in the older population. There is no disease-modifying therapy available for AD. The current standard of care drug therapy for AD is cholinesterase inhibitors, including donepezil. Bacopa monnieri or brahmi is u...
Na minha lista:
| Udgivet i: | Ann Indian Acad Neurol |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wolters Kluwer - Medknow
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7900738/ https://ncbi.nlm.nih.gov/pubmed/33688125 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/aian.AIAN_610_19 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|